Clinical Microbiology and Antimicrobial Chemotherapy. 2023; 25(1):106-112
Pulmonary aspergillosis has always been considered as a disease that occurs in patients with certain risk factors for its development. The COVID-19 pandemic has shown that fungal complications are common in patients without aspergillosis risk …